Kenzo Yamanaka
Department of Biochemical Toxicology
Nihon University College of Pharmacy
Funabashi
Chiba 274-8555
Japan
Name/email consistency: high
- The role of active arsenic species produced by metabolic reduction of dimethylarsinic acid in genotoxicity and tumorigenesis. Yamanaka, K., Kato, K., Mizoi, M., An, Y., Takabayashi, F., Nakano, M., Hoshino, M., Okada, S. Toxicol. Appl. Pharmacol. (2004)
- Oxidative DNA damage following exposure to dimethylarsinous iodide: the formation of cis-thymine glycol. Yamanaka, K., Mizoi, M., Tachikawa, M., Hasegawa, A., Hoshino, M., Okada, S. Toxicol. Lett. (2003)
- Oral administration of dimethylarsinic acid, a main metabolite of inorganic arsenic, in mice promotes skin tumorigenesis initiated by dimethylbenz(a)anthracene with or without ultraviolet B as a promoter. Yamanaka, K., Mizol, M., Kato, K., Hasegawa, A., Nakano, M., Okada, S. Biol. Pharm. Bull. (2001)
- Oral exposure of dimethylarsinic acid, a main metabolite of inorganic arsenics, in mice leads to an increase in 8-Oxo-2'-deoxyguanosine level, specifically in the target organs for arsenic carcinogenesis. Yamanaka, K., Takabayashi, F., Mizoi, M., An, Y., Hasegawa, A., Okada, S. Biochem. Biophys. Res. Commun. (2001)
- The role of orally administered dimethylarsinic acid, a main metabolite of inorganic arsenics, in the promotion and progression of UVB-induced skin tumorigenesis in hairless mice. Yamanaka, K., Katsumata, K., Ikuma, K., Hasegawa, A., Nakano, M., Okada, S. Cancer Lett. (2000)